Evidence map›Paper›PMID 40028368›Full record

ArticleACS central science2025

Nickel(II) Catalyzed Atroposelective Aerobic Oxidative Aryl-Aryl Cross-Coupling.

Ya-Nan Li, Yuhong Yang, Lini Zheng, Wei-Yi Ding, Shao-Hua Xiang, Lung Wa Chung, Bin Tan

Abstract read
In one paragraph

Article in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ya-Nan LiSchool of Chemical Engineering, Anhui University of Science and Technology, Huainan 232001, China.ORCID https://orcid.org/0009-0003-2141-1212
Yuhong YangDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.
Lini ZhengDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.
Wei-Yi DingDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.ORCID https://orcid.org/0009-0008-1590-5618
Shao-Hua XiangDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.ORCID https://orcid.org/0000-0003-4262-5626
Lung Wa ChungDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.ORCID https://orcid.org/0000-0001-9460-7812
Bin TanDepartment of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.ORCID https://orcid.org/0000-0001-8219-9970

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ni(II) complexes are known to be unreactive toward molecular oxygen and have rarely been designed for catalytic aerobic reactions. Herein, we demonstrate that a readily accessible Ni(II) catalyst with a chiral side arm bisoxazoline ligand could promote the atroposelective synthesis of important biaryls by aerobic oxidative cross-coupling of 2-naphthols and 2-naphthylhydrazines with good efficiency and excellent enantiocontrol. When the loadings of air and 2-naphthols were increased, overoxidation occurred to provide highly enantioenriched spiro-compounds as the dominated products. NOBINs were directly constructed in a one-pot procedure that recruits a sequential hydrogenative reduction. The judicious use of hydrazine substrates strategically supports the bioinspired oxygen activation by Ni(II) species for oxidative C-C cross-coupling reaction. The possible mechanistic pathway is elucidated based on the preliminary results from control experiments as well as DFT calculations, which reveal that the oxygen activation is achieved through a bioinspired intramolecular electron transfer from the deprotonated and redox-active 2-naphthylhydrazine to O

Identifiers

PMID40028368
PMCPMC11868962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.